Sarepta Therapeutics
Open
$21.14
Prev. Close
$21.14
High
$21.14
Low
$21.12
Market Snapshot
$2.17B
-3.0
2.47
$1.9B
835
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
emptyResult
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Recently from Cashu
Sarepta Therapeutics Pursues FDA Approval Amidst Investor Concerns Over Stock Decline
Sarepta Therapeutics Advances Regulatory Strategy Amid Investor Concerns Sarepta Therapeutics is currently focused on submitting supplemental new drug applications to the U.S. Food and Drug Administra…
Sarepta Navigates New FDA Leadership Changes Impacting Gene Therapy Regulations
Sarepta Therapeutics Enters a New Era of Regulatory Dynamics Amidst Leadership Changes at the FDA Sarepta Therapeutics, a leader in gene therapy innovations for genetic diseases, is positioned at a cr…
Regulatory Changes Could Boost Sarepta Therapeutics' Gene Therapy Innovations
Regulatory Shifts Signal Opportunities for Biopharmaceutical Innovation Sarepta Therapeutics stands at a potentially transformative juncture in the gene therapy landscape as the U.S. Food and Drug Adm…
Sarepta Therapeutics Faces Regulatory Scrutiny Amid FDA's Shifting Approval Standards for Rare Diseases
Sarepta Therapeutics Navigates Regulatory Challenges Amid FDA Scrutiny In light of recent developments within the biopharmaceutical landscape, Sarepta Therapeutics remains at a pivotal crossroads as r…